Search research articles
Contact Us
Filters
Showing results (61-70 of 64) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 64 results.
Journal of Clinical Microbiology
|
March 24, 2012
Extensive genetic diversity within the Dutch clinical Cryptococcus neoformans population
Ferry Hagen, María-Teresa Illnait-Zaragozí, Jacques F Meis, et al.
The Journal of Antimicrobial Chemotherapy
|
July 2, 2011
Eradication of carriage with methicillin-resistant Staphylococcus aureus: determinants of treatment failure
Heidi S M Ammerlaan, Jan A J W Kluytmans, Hanneke Berkhout, et al.
The Journal of Antimicrobial Chemotherapy
|
July 2, 2011
Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline
Heidi S M Ammerlaan, Jan A J W Kluytmans, Hanneke Berkhout, et al.
Lancet (London, England)
|
January 24, 2015
The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial
Willeke F Westendorp, Jan-Dirk Vermeij, Elles Zock, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 64) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 64 results.
Journal of Clinical Microbiology
|
March 24, 2012
Extensive genetic diversity within the Dutch clinical Cryptococcus neoformans population
Ferry Hagen, María-Teresa Illnait-Zaragozí, Jacques F Meis, et al.
The Journal of Antimicrobial Chemotherapy
|
July 2, 2011
Eradication of carriage with methicillin-resistant Staphylococcus aureus: determinants of treatment failure
Heidi S M Ammerlaan, Jan A J W Kluytmans, Hanneke Berkhout, et al.
The Journal of Antimicrobial Chemotherapy
|
July 2, 2011
Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline
Heidi S M Ammerlaan, Jan A J W Kluytmans, Hanneke Berkhout, et al.
Lancet (London, England)
|
January 24, 2015
The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial
Willeke F Westendorp, Jan-Dirk Vermeij, Elles Zock, et al.
Page
of 7